NYR 1.61% 6.3¢ nyrada inc.

Ann: Nyrada Commences Walter Reed Traumatic Brain Injury Study, page-3

  1. 1,334 Posts.
    lightbulb Created with Sketch. 430
    Pre-clinical study.

    Agree it is undervalued, however AGN is several years ahead on the clinical timeline - having completed a phase 1 and started dosing in a placebo-controlled double-blind phase 2. Plus ODD designation for HIE. I'd argue that AGN is also undervalued.
 
watchlist Created with Sketch. Add NYR (ASX) to my watchlist
(20min delay)
Last
6.3¢
Change
0.001(1.61%)
Mkt cap ! $11.30M
Open High Low Value Volume
6.4¢ 6.4¢ 6.3¢ $7.999K 125.7K

Buyers (Bids)

No. Vol. Price($)
1 31745 6.3¢
 

Sellers (Offers)

Price($) Vol. No.
6.6¢ 9000 1
View Market Depth
Last trade - 16.10pm 23/05/2024 (20 minute delay) ?
Last
6.4¢
  Change
0.001 ( 1.59 %)
Open High Low Volume
6.4¢ 6.5¢ 6.4¢ 30001
Last updated 15.15pm 23/05/2024 ?
NYR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.